$DBVT

2024 Q4 Form 10-Q Financial Statement

#000161378024000007 Filed on November 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $1.072M
YoY Change -54.81%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $7.739M
YoY Change 13.03%
% of Gross Profit
Research & Development $23.66M
YoY Change 71.53%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $31.40M
YoY Change 52.12%
Operating Profit -$30.33M
YoY Change 66.0%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$30.44M
YoY Change 81.9%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$30.44M
YoY Change 81.9%
Net Earnings / Revenue -2839.74%
Basic Earnings Per Share -$0.32
Diluted Earnings Per Share -$0.32
COMMON SHARES
Basic Shares Outstanding 96.50M shares 96.50M
Diluted Shares Outstanding 96.20M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $46.44M
Short-Term Investments
Other Short-Term Assets $22.32M
YoY Change 10.84%
Inventory
Prepaid Expenses $2.215M
Receivables
Other Receivables
Total Short-Term Assets $68.76M
YoY Change -59.38%
LONG-TERM ASSETS
Property, Plant & Equipment $12.98M
YoY Change -0.84%
Goodwill
YoY Change
Intangibles $43.00K
YoY Change -29.51%
Long-Term Investments
YoY Change
Other Assets $5.280M
YoY Change -11.56%
Total Long-Term Assets $24.30M
YoY Change 18.44%
TOTAL ASSETS
Total Short-Term Assets $68.76M
Total Long-Term Assets $24.30M
Total Assets $93.06M
YoY Change -50.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $30.91M
YoY Change -1.69%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities $0.00
YoY Change -100.0%
Total Long-Term Liabilities $8.109M
YoY Change -43.49%
TOTAL LIABILITIES
Total Short-Term Liabilities $30.91M
Total Long-Term Liabilities $8.109M
Total Liabilities $39.02M
YoY Change -14.79%
SHAREHOLDERS EQUITY
Retained Earnings -$263.3M
YoY Change 15.66%
Common Stock $10.98M
YoY Change 0.24%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $54.03M
YoY Change
Total Liabilities & Shareholders Equity $93.06M
YoY Change -50.97%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$30.44M
YoY Change 81.9%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001613780
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2024Q2 dei Entity Listing Depository Receipt Ratio
EntityListingDepositoryReceiptRatio
0.5
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36697
dei Entity Registrant Name
EntityRegistrantName
DBV TECHNOLOGIES S.A.
dei Entity Address Country
EntityAddressCountry
FR
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
I0
dei Entity Address Address Line1
EntityAddressAddressLine1
107 Av. de la République
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92320
dei Entity Address City Or Town
EntityAddressCityOrTown
Châtillon
dei Country Region
CountryRegion
+33
dei Local Phone Number
LocalPhoneNumber
1 55 42 78 78
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
96501526 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46441000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
141367000 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
22318000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
17548000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
68759000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
158915000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12984000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12623000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5988000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5247000 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
43000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
58000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5280000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6144000 usd
CY2024Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
24296000 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
24071000 usd
CY2024Q3 us-gaap Assets
Assets
93055000 usd
CY2023Q4 us-gaap Assets
Assets
182986000 usd
CY2024Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
22500000 usd
CY2023Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
23302000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
374000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1144000 usd
CY2024Q3 dbvt Provision For Liabilities Current
ProvisionForLiabilitiesCurrent
253000 usd
CY2023Q4 dbvt Provision For Liabilities Current
ProvisionForLiabilitiesCurrent
3959000 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7786000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8934000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
30913000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
37339000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7038000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4526000 usd
CY2024Q3 dbvt Provision For Liabilities Noncurrent
ProvisionForLiabilitiesNoncurrent
1070000 usd
CY2023Q4 dbvt Provision For Liabilities Noncurrent
ProvisionForLiabilitiesNoncurrent
935000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 usd
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
8109000 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
5461000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
39021000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
42799000 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.1
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.1
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
96501526 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
96501526 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
96431770 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
96431770 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
10979000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
10972000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
316102000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
377468000 usd
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
297180 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
222988 shares
CY2024Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1351000 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1263000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-263332000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-238862000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
709000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
742000 usd
CY2024Q3 dbvt Accumulated Foreign Currency Translation Adjustment Net Of Tax
AccumulatedForeignCurrencyTranslationAdjustmentNetOfTax
-9073000 usd
CY2023Q4 dbvt Accumulated Foreign Currency Translation Adjustment Net Of Tax
AccumulatedForeignCurrencyTranslationAdjustmentNetOfTax
-8871000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
54034000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
140187000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
93055000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
182986000 usd
CY2024Q3 us-gaap Revenues
Revenues
1072000 usd
CY2023Q3 us-gaap Revenues
Revenues
2372000 usd
us-gaap Revenues
Revenues
3640000 usd
us-gaap Revenues
Revenues
6853000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23662000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13795000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
70438000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
47448000 usd
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
519000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
663000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2263000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1613000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7220000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6184000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23667000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22304000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
31401000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
20642000 usd
us-gaap Operating Expenses
OperatingExpenses
96368000 usd
us-gaap Operating Expenses
OperatingExpenses
71365000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-30328000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-18270000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-92728000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-64512000 usd
CY2024Q3 dbvt Finance Income Expenses
FinanceIncomeExpenses
-113000 usd
CY2023Q3 dbvt Finance Income Expenses
FinanceIncomeExpenses
1534000 usd
dbvt Finance Income Expenses
FinanceIncomeExpenses
1873000 usd
dbvt Finance Income Expenses
FinanceIncomeExpenses
2984000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30442000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16736000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-90855000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-61527000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-30442000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-16736000 usd
us-gaap Net Income Loss
NetIncomeLoss
-90903000 usd
us-gaap Net Income Loss
NetIncomeLoss
-61540000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3825000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3996000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-202000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-551000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
-41000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
73000 usd
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
-33000 usd
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
-19000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26658000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20659000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-91138000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-62111000 usd
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.32
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.32
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.95
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.95
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.65
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.65
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
96201476 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
96201476 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
96075540 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
96075540 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
96187868 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
96187868 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
94801569 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
94801569 shares
us-gaap Net Income Loss
NetIncomeLoss
-90903000 usd
us-gaap Net Income Loss
NetIncomeLoss
-61540000 usd
dbvt Adjustment For Depreciation Amortization And Accrued Contingencies
AdjustmentForDepreciationAmortizationAndAccruedContingencies
-1563000 usd
dbvt Adjustment For Depreciation Amortization And Accrued Contingencies
AdjustmentForDepreciationAmortizationAndAccruedContingencies
-3072000 usd
dbvt Adjustment For Retirement Pension Obligations
AdjustmentForRetirementPensionObligations
87000 usd
dbvt Adjustment For Retirement Pension Obligations
AdjustmentForRetirementPensionObligations
58000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
5073000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
4800000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-582000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-23000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
4153000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
5850000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-1090000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1691000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1225000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-2547000 usd
dbvt Increase Decrease In Operating Lease Liability And Right Of Use Asset
IncreaseDecreaseInOperatingLeaseLiabilityAndRightOfUseAsset
-970000 usd
dbvt Increase Decrease In Operating Lease Liability And Right Of Use Asset
IncreaseDecreaseInOperatingLeaseLiabilityAndRightOfUseAsset
-471000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-92222000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-65967000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2463000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
325000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
171000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
54000 usd
dbvt Proceeds Of Non Current Financial Assets
ProceedsOfNonCurrentFinancialAssets
1084000 usd
dbvt Proceeds Of Non Current Financial Assets
ProceedsOfNonCurrentFinancialAssets
-242000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1550000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-621000 usd
us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
0 usd
us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
0 usd
dbvt Proceeds From Payment For Treasury Stock
ProceedsFromPaymentForTreasuryStock
-88000 usd
dbvt Proceeds From Payment For Treasury Stock
ProceedsFromPaymentForTreasuryStock
54000 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
6902000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-88000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6956000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-1065000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-427000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-94925000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-60059000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
141367000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
209194000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46441000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
149135000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
194453000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-20561000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3584000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 usd
CY2023Q1 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
-14000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1632000 usd
CY2023Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
0 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
179094000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-24243000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-232000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7766000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
0 usd
CY2023Q2 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
42000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1814000 usd
CY2023Q2 dbvt Adjustments To Additional Paid In Capital Allocation Of Accumulated Gain Loss Net
AdjustmentsToAdditionalPaidInCapitalAllocationOfAccumulatedGainLossNet
0 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
164240000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-16736000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3922000 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-864000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
0 usd
CY2023Q3 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
-81000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1354000 usd
CY2023Q3 us-gaap Stockholders Equity Other
StockholdersEquityOther
0 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
143991000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
140187000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-27345000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3084000 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 usd
CY2024Q1 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
-62000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1958000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
111654000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-33116000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-934000 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 usd
CY2024Q2 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
-33000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1525000 usd
CY2024Q2 dbvt Adjustments To Additional Paid In Capital Allocation Of Accumulated Gain Loss Net
AdjustmentsToAdditionalPaidInCapitalAllocationOfAccumulatedGainLossNet
0 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
79095000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-30442000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3784000 usd
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 usd
CY2024Q3 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
7000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1590000 usd
CY2024Q3 dbvt Adjustments To Additional Paid In Capital Allocation Of Accumulated Gain Loss Net
AdjustmentsToAdditionalPaidInCapitalAllocationOfAccumulatedGainLossNet
0 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
54034000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:400;line-height:120%">Use of estimates</span></div><div style="margin-bottom:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The preparation of the Company’s condensed consolidated financial statements requires the use of estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amount of income and expenses during the period. The Company bases its estimates and assumptions on historical experience and other factors that it believes to be reasonable under the circumstances. The Company evaluates its estimates and assumptions on an ongoing basis. The actual results may differ from these estimates. </span></div>On an on-going basis, management evaluates its estimates, primarily those related to: (1) evaluation of costs and measure of progress of the wind-down activities resulting from the termination of the collaboration agreement with Nestlé Health Science, (2) research tax credits, (3) assumptions used in the valuation of right of use assets—operating lease, (4) impairment of right-of-use assets related to leases and property, plant and equipment, (5) recoverability of the Company’s net deferred tax assets and related valuation allowance, (6) assumptions used in the valuation model to determine the fair value and vesting conditions of share-based compensation plan, (7) estimate of contingencies, and (8) estimate of employee benefits obligations.
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46400000 usd
CY2021Q1 dbvt Number Of Patches
NumberOfPatches
5 patch
CY2023Q3 dbvt Number Of Additional Safety Study
NumberOfAdditionalSafetyStudy
2 study
CY2024Q2 dei Entity Listing Depository Receipt Ratio
EntityListingDepositoryReceiptRatio
1
CY2024Q2 dei Entity Listing Depository Receipt Ratio
EntityListingDepositoryReceiptRatio
1
CY2024Q2 dbvt Depository Shares Exchange Ratio
DepositorySharesExchangeRatio
2
CY2024Q2 dbvt Depository Shares Exchange Ratio
DepositorySharesExchangeRatio
2
CY2024Q3 us-gaap Cash
Cash
18451000 usd
CY2023Q4 us-gaap Cash
Cash
10530000 usd
CY2024Q3 dbvt Cash Equivalent Term Deposits
CashEquivalentTermDeposits
27990000 usd
CY2023Q4 dbvt Cash Equivalent Term Deposits
CashEquivalentTermDeposits
130836000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46441000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
141367000 usd
CY2024Q3 us-gaap Bank Overdrafts
BankOverdrafts
usd
CY2023Q4 us-gaap Bank Overdrafts
BankOverdrafts
usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46441000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
141367000 usd
CY2024Q3 dbvt Cash Equivalent Convertible Into Cash Period
CashEquivalentConvertibleIntoCashPeriod
P32D
CY2024Q3 dbvt Research Tax Credit
ResearchTaxCredit
9649000 usd
CY2023Q4 dbvt Research Tax Credit
ResearchTaxCredit
8857000 usd
CY2024Q3 us-gaap Prepaid Taxes
PrepaidTaxes
5610000 usd
CY2023Q4 us-gaap Prepaid Taxes
PrepaidTaxes
5236000 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2215000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2103000 usd
CY2024Q3 dbvt Other Receivables Current
OtherReceivablesCurrent
4844000 usd
CY2023Q4 dbvt Other Receivables Current
OtherReceivablesCurrent
1353000 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
22318000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
17548000 usd
CY2023Q4 dbvt Research Tax Credit Receivable
ResearchTaxCreditReceivable
8857000 usd
dbvt Research Tax Credit Operating Income
ResearchTaxCreditOperatingIncome
3640000 usd
dbvt Research Tax Credit Payment Received
ResearchTaxCreditPaymentReceived
2985000 usd
dbvt Research Tax Credit Adjustment And Currency Translation Effect
ResearchTaxCreditAdjustmentAndCurrencyTranslationEffect
137000 usd
CY2024Q3 dbvt Research Tax Credit Receivable
ResearchTaxCreditReceivable
9649000 usd
CY2024Q3 dbvt Research Tax Credit Non Current
ResearchTaxCreditNonCurrent
0 usd
CY2024Q3 dbvt Research Tax Credit Current
ResearchTaxCreditCurrent
9649000 usd
CY2023 dbvt Tax Credit Carryforward Amount Before Currency Translation
TaxCreditCarryforwardAmountBeforeCurrencyTranslation
8900000 usd
dbvt Research Tax Credit Payment Received
ResearchTaxCreditPaymentReceived
3000000.0 usd
CY2023 dbvt Research Tax Credit Awaiting Reimbursement
ResearchTaxCreditAwaitingReimbursement
6000000 usd
dbvt Tax Credit Carryforward Amount Before Currency Translation
TaxCreditCarryforwardAmountBeforeCurrencyTranslation
3600000 usd
CY2024Q3 dbvt Other Receivables Relating To The Service Agreement
OtherReceivablesRelatingToTheServiceAgreement
3300000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
482000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1284000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1487000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
75000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1302000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
421000 usd
CY2024Q3 dbvt Lessee Operating Lease Liability To Be Paid Due After Year Two
LesseeOperatingLeaseLiabilityToBePaidDueAfterYearTwo
5804000 usd
CY2023Q4 dbvt Lessee Operating Lease Liability To Be Paid Due After Year Two
LesseeOperatingLeaseLiabilityToBePaidDueAfterYearTwo
5515000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
9075000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
7295000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1664000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1626000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
7412000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
5670000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
374000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1144000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7038000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4526000 usd
CY2024Q3 dbvt Increase Decrease In Operating Lease Liability Noncurrent
IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent
1700000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
1568000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
1223000 usd
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
46000 usd
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
92000 usd
dbvt Gain Loss On Restructuring Of Lease
GainLossOnRestructuringOfLease
0 usd
dbvt Gain Loss On Restructuring Of Lease
GainLossOnRestructuringOfLease
0 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
1141000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
1410000 usd
dbvt Increase Decrease In Accounts Payable Trade Net Of Foreign Exchange Impact
IncreaseDecreaseInAccountsPayableTradeNetOfForeignExchangeImpact
-800000 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7786000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 usd
CY2024Q3 us-gaap Other Liabilities
OtherLiabilities
7786000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8934000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 usd
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
8934000 usd
CY2024Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.10
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1590000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1353000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5073000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4800000 usd
us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<div style="margin-bottom:10pt;margin-top:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Note 9: Contingencies</span></div><div style="margin-bottom:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The following tables summarize the contingencies as of September 30, 2024 and December 31, 2023:</span></div><div style="margin-bottom:8pt;margin-top:2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.466%"><tr><td style="width:1.0%"></td><td style="width:65.210%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.210%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.213%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#c9e8fb;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Current contingencies</span></td><td colspan="2" style="background-color:#c9e8fb;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">253 </span></td><td style="background-color:#c9e8fb;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c9e8fb;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#c9e8fb;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3,959 </span></td><td style="background-color:#c9e8fb;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Non-current contingencies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,070 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">935 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c9e8fb;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total contingencies</span></td><td colspan="2" style="background-color:#c9e8fb;border-bottom:2pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">1,323</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#c9e8fb;border-bottom:2pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c9e8fb;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#c9e8fb;border-bottom:2pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">4,894</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#c9e8fb;border-bottom:2pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The changes in contingencies are as follows:</span></div><div style="margin-bottom:8pt;margin-top:2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.617%"><tr><td style="width:1.0%"></td><td style="width:30.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.865%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.865%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.865%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.188%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Pension retirement obligations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Collaboration agreement - Loss at completion<br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Other contingencies</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#c9e8fb;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">At January 1, 2024</span></td><td colspan="2" style="background-color:#c9e8fb;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">935</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#c9e8fb;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c9e8fb;padding:0 1pt"></td><td colspan="2" style="background-color:#c9e8fb;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2,100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#c9e8fb;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c9e8fb;padding:0 1pt"></td><td colspan="2" style="background-color:#c9e8fb;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">1,859</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#c9e8fb;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c9e8fb;padding:0 1pt"></td><td colspan="2" style="background-color:#c9e8fb;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">4,894</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#c9e8fb;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Increases in liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">87 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">73 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">159 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c9e8fb;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Used liabilities</span></td><td colspan="2" style="background-color:#c9e8fb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#c9e8fb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c9e8fb;padding:0 1pt"></td><td colspan="2" style="background-color:#c9e8fb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1,930)</span></td><td style="background-color:#c9e8fb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c9e8fb;padding:0 1pt"></td><td colspan="2" style="background-color:#c9e8fb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1,136)</span></td><td style="background-color:#c9e8fb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c9e8fb;padding:0 1pt"></td><td colspan="2" style="background-color:#c9e8fb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3,066)</span></td><td style="background-color:#c9e8fb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Reversals of unused liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(656)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(656)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c9e8fb;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net interest related to employee benefits, and unwinding of discount </span></td><td colspan="2" style="background-color:#c9e8fb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#c9e8fb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c9e8fb;padding:0 1pt"></td><td colspan="2" style="background-color:#c9e8fb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#c9e8fb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c9e8fb;padding:0 1pt"></td><td colspan="2" style="background-color:#c9e8fb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#c9e8fb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c9e8fb;padding:0 1pt"></td><td colspan="2" style="background-color:#c9e8fb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#c9e8fb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Actuarial gains and losses on defined-benefit plans</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">33 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">33 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c9e8fb;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Currency translation effect</span></td><td colspan="2" style="background-color:#c9e8fb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">16 </span></td><td style="background-color:#c9e8fb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c9e8fb;padding:0 1pt"></td><td colspan="2" style="background-color:#c9e8fb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(30)</span></td><td style="background-color:#c9e8fb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c9e8fb;padding:0 1pt"></td><td colspan="2" style="background-color:#c9e8fb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(27)</span></td><td style="background-color:#c9e8fb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c9e8fb;padding:0 1pt"></td><td colspan="2" style="background-color:#c9e8fb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(41)</span></td><td style="background-color:#c9e8fb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">At September 30, 2024</span></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">1,070</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">141</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">112</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">1,323</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#c9e8fb;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Of which current </span></td><td colspan="2" style="background-color:#c9e8fb;border-top:2pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">— </span></td><td style="background-color:#c9e8fb;border-top:2pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c9e8fb;padding:0 1pt"></td><td colspan="2" style="background-color:#c9e8fb;border-top:2pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">141 </span></td><td style="background-color:#c9e8fb;border-top:2pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c9e8fb;padding:0 1pt"></td><td colspan="2" style="background-color:#c9e8fb;border-top:2pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">112 </span></td><td style="background-color:#c9e8fb;border-top:2pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#c9e8fb;padding:0 1pt"></td><td colspan="2" style="background-color:#c9e8fb;border-top:2pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">253 </span></td><td style="background-color:#c9e8fb;border-top:2pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Of which non-current </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">1,070 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">1,070 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">In May 2016, the Company entered into a Development Collaboration and License Agreement (the “Collaboration Agreement”) with Societe des Produits Nestle S.A. (formerly, NESTEC S.A.) (“NESTEC”) under which the Company was responsible for leading the development activities of MAG1C up through a pivotal phase 3 clinical program. On October 30, 2023, the Company signed a Mutual Termination Letter Agreement with NESTEC terminating the Collaboration Agreement between the parties. As of September 30, 2024, the accrual for ongoing Clinical study completion totals $0.1 million as compared to $2.1 million as of December 31, 2023 representing our best estimate of the remaining expenses related to the ongoing clinical study.</span></div><div style="margin-bottom:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">An amount of $1.8 million reserved for the refurbishment of the previous Montrouge offices was reversed in the second quarter of 2024. </span></div>The Company does not hold any plan assets related to long-term employee benefit for any of the periods presented. There have been no significant changes in assumptions for the estimation of the retirement commitments from those disclosed in Note 13 to the consolidated financial statements included in the Annual Report.
CY2024Q3 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
253000 usd
CY2023Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
3959000 usd
CY2024Q3 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
1070000 usd
CY2023Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
935000 usd
CY2024Q3 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Current And Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent
1323000 usd
CY2023Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Current And Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent
4894000 usd
CY2023Q4 dbvt Defined Benefit Plan Benefit Obligation And Loss Contingency Accrual
DefinedBenefitPlanBenefitObligationAndLossContingencyAccrual
4894000 usd
dbvt Defined Benefit Plan Benefit Obligation And Loss Contingency Accrual Increase In Provision
DefinedBenefitPlanBenefitObligationAndLossContingencyAccrualIncreaseInProvision
159000 usd
dbvt Loss Contingency Accrual Liabilities Used
LossContingencyAccrualLiabilitiesUsed
3066000 usd
us-gaap Loss Contingency Accrual Carrying Value Period Increase Decrease
LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
-656000 usd
us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-33000 usd
dbvt Defined Benefit Plan Benefit Obligation And Loss Contingency Accrual Foreign Currency Translation Gain Loss
DefinedBenefitPlanBenefitObligationAndLossContingencyAccrualForeignCurrencyTranslationGainLoss
41000 usd
CY2024Q3 dbvt Defined Benefit Plan Benefit Obligation And Loss Contingency Accrual
DefinedBenefitPlanBenefitObligationAndLossContingencyAccrual
1323000 usd
CY2024Q3 dbvt Liability Defined Benefit Plan And Loss Contingency Current
LiabilityDefinedBenefitPlanAndLossContingencyCurrent
253000 usd
CY2024Q3 dbvt Liability Defined Benefit Plan And Loss Contingency Noncurrent
LiabilityDefinedBenefitPlanAndLossContingencyNoncurrent
1070000 usd
CY2024Q3 dbvt Accrued Contract Expenses
AccruedContractExpenses
100000 usd
CY2023Q4 dbvt Accrued Contract Expenses
AccruedContractExpenses
2100000 usd
CY2024Q3 dbvt Refurbishment Reserve Reversed
RefurbishmentReserveReversed
1800000 usd
CY2024Q3 dbvt Research Tax Credit Income
ResearchTaxCreditIncome
1072000 usd
CY2023Q3 dbvt Research Tax Credit Income
ResearchTaxCreditIncome
1237000 usd
dbvt Research Tax Credit Income
ResearchTaxCreditIncome
3640000 usd
dbvt Research Tax Credit Income
ResearchTaxCreditIncome
4978000 usd
CY2024Q3 us-gaap Other Operating Income
OtherOperatingIncome
0 usd
CY2023Q3 us-gaap Other Operating Income
OtherOperatingIncome
1134000 usd
us-gaap Other Operating Income
OtherOperatingIncome
0 usd
us-gaap Other Operating Income
OtherOperatingIncome
1875000 usd
CY2024Q3 us-gaap Revenues
Revenues
1072000 usd
CY2023Q3 us-gaap Revenues
Revenues
2372000 usd
us-gaap Revenues
Revenues
3640000 usd
us-gaap Revenues
Revenues
6853000 usd
CY2024Q3 dei Entity Number Of Employees
EntityNumberOfEmployees
108 employee
CY2023Q3 dei Entity Number Of Employees
EntityNumberOfEmployees
97 employee
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
dbvt-20240930_cal.xml Edgar Link unprocessable
0001613780-24-000007-index-headers.html Edgar Link pending
0001613780-24-000007-index.html Edgar Link pending
0001613780-24-000007.txt Edgar Link pending
0001613780-24-000007-xbrl.zip Edgar Link pending
bylaws-dbv10xq_updatedsept.htm Edgar Link pending
dbvt-20240930.htm Edgar Link pending
dbvt-20240930.xsd Edgar Link pending
exhibit311-dbv_10xqxq3x2024.htm Edgar Link pending
exhibit312-dbv_10xqxq3x2024.htm Edgar Link pending
exhibit321-dbv_10xqxq3x2024.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
dbvt-20240930_def.xml Edgar Link unprocessable
dbvt-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
dbvt-20240930_htm.xml Edgar Link completed
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
dbvt-20240930_lab.xml Edgar Link unprocessable